Home / BusinessBusinessBloombergBusinessBloomberg·Sep 3, 2026·1 min readAstraZeneca, Sanofi, Boehringer Back Owkin AI to Cut Drug BottlenecksAI can produce thousands of drug ideas in seconds.View original source — Bloomberg ↗ShareCopy linkShare on XShare on FacebookRelated storiesBusinessBloombergBusinessSep 2, 2026 · 1 minBoehringer Signs Deal for Owkin AI, Joining Astra and SanofiBloombergBusinessFinancial TimesBusinessSep 2, 2026 · 1 minThe race to stop AI from designing bioweaponsFinancial TimesBusinessCNABusinessSep 2, 2026 · 1 minOwkin signs AI drug discovery deal with Boehringer for cancer, immunologyCNAWorldNatureWorldJun 8, 2026 · 1 minAI is taking on antibiotic resistance — here’s howNature
BusinessBloombergBusinessSep 2, 2026 · 1 minBoehringer Signs Deal for Owkin AI, Joining Astra and SanofiBloomberg
BusinessFinancial TimesBusinessSep 2, 2026 · 1 minThe race to stop AI from designing bioweaponsFinancial Times
BusinessCNABusinessSep 2, 2026 · 1 minOwkin signs AI drug discovery deal with Boehringer for cancer, immunologyCNA